# Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen

> **NCT02974361** · PHASE1 · COMPLETED · sponsor: **Oxford Pharmascience Ltd** · enrollment: 30 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Ibuprofen
- **DRUG:** Ibuprofen Lysine
- **DRUG:** Ibuprofen-LDH

## Key facts

- **NCT ID:** NCT02974361
- **Lead sponsor:** Oxford Pharmascience Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-04-28
- **Final completion:** 2017-05-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02974361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02974361, "Impact of Excipients on Pharmacokinetics of OXPzero(TM) Ibuprofen". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02974361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*